Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
198 studies found for:    Open Studies | "Hypertension, Pulmonary"
Show Display Options
Rank Status Study
21 Unknown  Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
Conditions: Systemic Sclerosis;   Shortness of Breath;   Pulmonary Hypertension
Intervention: Drug: Ambrisentan
22 Recruiting Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
Condition: Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Interventions: Drug: Adempas, Riociguat (BAY63-2521);   Device: Placebo
23 Recruiting Database for Clinical and Anamnestic Data in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention:
24 Recruiting Trans-pulmonary Biomarkers in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention:
25 Unknown  Inspiratory Muscle Training in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Other: Inspiratory muscle training
26 Available Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Adempas (Riociguat, BAY63-2521)
27 Unknown  Immunoadsorption in Patients With Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Pulmonary Resistance
Intervention: Procedure: immunoadsorption / immunglobulin substitution
28 Unknown  Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis;   Nonspecific Interstitial Pneumonia
Interventions: Drug: Bosentan;   Drug: Placebo
29 Recruiting Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Pulmonary Arterial Hypertension;   Cardiovascular Diseases;   Lung Diseases;   Tanshinone IIA Sulfonate
Interventions: Drug: 20 mg sildenafil  citrate by mouth;   Drug: sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth
30 Not yet recruiting Safety Procedure Pulmonary Artery Denervation in Addition to Pulmonary Vein Isolation Combined With Ganglionated Plexi Ablation in Patients With Persistent Atrial Fibrillation and Pulmonary Hypertension
Conditions: Atrial Fibrillation;   Hypertension, Pulmonary;   Heart Diseases;   Arrhythmias, Cardiac;   Pathologic Processes;   Cardiovascular Diseases;   Lung Diseases
Interventions: Procedure: PV isolation + GP Ablation;   Procedure: PV isolation + GP ablation + Pulmonary GP ablation
31 Unknown  Pulmonary Hypertension: Efficacy of a 3 Week Inpatient Rehabilitation on Physical Condition, Body Composition and Health Related Quality of Life
Condition: Pulmonary Hypertension: Efficacy of Rehabilitation
Intervention:
32 Recruiting Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Conditions: Systemic Sclerosis;   Scleroderma;   Pulmonary Hypertension;   Pulmonary Arterial Hypertension
Intervention:
33 Recruiting Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years
Condition: Pulmonary Hypertension
Intervention: Drug: Ventavis inhaled (Iloprost, BAYQ6256)
34 Recruiting Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study
Condition: Pulmonary Hypertension
Intervention: Radiation: Cardiac Magnetic Resonance Imaging (MRI)
35 Recruiting Ablation of the Pulmonary Artery With High Pulmonary Hypertension During Mitral Valve Surgery
Condition: Pulmonary Hypertension
Interventions: Procedure: Surgical ablation of ganglion plexus pulmonary artery.;   Procedure: mitral valve surgery
36 Unknown  Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Interventions: Procedure: Right heart catheterization;   Procedure: Near-infrared spectroscopy
37 Not yet recruiting PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Mitral Valve Surgery
Interventions: Drug: Sildenafil;   Drug: Placebo
38 Recruiting Targeting the Right Ventricle in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Interventions: Drug: Ranolazine;   Drug: Placebo
39 Recruiting A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn
Condition: Pulmonary Hypertension, Familial Persistent, of the Newborn
Interventions: Drug: placebo;   Drug: iv sildenafil
40 Recruiting 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Interventions: Drug: 11C-acetate;   Drug: [18F]Fluoro-2-deoxy-2-D-glucose;   Other: Cardiac MRI

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years